IART
Integra Lifesciences Holdings·NASDAQ
--
--(--)
--
--(--)
1.14 / 10
Underperform
Fundamental analysis rates the equity poorly at 1.1/10. Key weaknesses include negative Net income-Revenue and Cash-MV metrics, while only a few factors like Net profit attributable to parent company shareholders / Net profit (%) and Asset-MV show marginal strength. Historical back-tests for these factors mostly indicate negative one-month returns, reinforcing the underperform label.
Analysis Checks(4/10)
Revenue-MV
Value0.97
Score1/3
Weight10.52%
1M Return-1.83%
Value0.97
Score1/3
Weight10.52%
1M Return-1.83%
Net profit attributable to parent company shareholders / Net profit (%)
Value100.00
Score2/3
Weight10.63%
1M Return-1.71%
Value100.00
Score2/3
Weight10.63%
1M Return-1.71%
Cash-UP
Value1.07
Score2/3
Weight25.91%
1M Return-4.86%
Value1.07
Score2/3
Weight25.91%
1M Return-4.86%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight11.98%
1M Return-1.95%
Value15.48
Score2/3
Weight11.98%
1M Return-1.95%
Cash-MV
Value0.14
Score1/3
Weight28.47%
1M Return-5.64%
Value0.14
Score1/3
Weight28.47%
1M Return-5.64%
ROA (%)
Value-13.40
Score1/3
Weight3.85%
1M Return-0.54%
Value-13.40
Score1/3
Weight3.85%
1M Return-0.54%
Net income-Revenue
Value-0.17
Score1/3
Weight15.01%
1M Return-2.55%
Value-0.17
Score1/3
Weight15.01%
1M Return-2.55%
Annualized net profit margin on total assets (%)
Value-17.86
Score1/3
Weight3.85%
1M Return-0.54%
Value-17.86
Score1/3
Weight3.85%
1M Return-0.54%
Asset-MV
Value-0.50
Score3/3
Weight-26.49%
1M Return3.31%
Value-0.50
Score3/3
Weight-26.49%
1M Return3.31%
Net profit / Total profit (%)
Value90.66
Score1/3
Weight16.25%
1M Return-2.89%
Value90.66
Score1/3
Weight16.25%
1M Return-2.89%
Revenue-MV
Value0.97
Score1/3
Weight10.52%
1M Return-1.83%
Value0.97
Score1/3
Weight10.52%
1M Return-1.83%
ROA (%)
Value-13.40
Score1/3
Weight3.85%
1M Return-0.54%
Value-13.40
Score1/3
Weight3.85%
1M Return-0.54%
Net profit attributable to parent company shareholders / Net profit (%)
Value100.00
Score2/3
Weight10.63%
1M Return-1.71%
Value100.00
Score2/3
Weight10.63%
1M Return-1.71%
Net income-Revenue
Value-0.17
Score1/3
Weight15.01%
1M Return-2.55%
Value-0.17
Score1/3
Weight15.01%
1M Return-2.55%
Cash-UP
Value1.07
Score2/3
Weight25.91%
1M Return-4.86%
Value1.07
Score2/3
Weight25.91%
1M Return-4.86%
Annualized net profit margin on total assets (%)
Value-17.86
Score1/3
Weight3.85%
1M Return-0.54%
Value-17.86
Score1/3
Weight3.85%
1M Return-0.54%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight11.98%
1M Return-1.95%
Value15.48
Score2/3
Weight11.98%
1M Return-1.95%
Asset-MV
Value-0.50
Score3/3
Weight-26.49%
1M Return3.31%
Value-0.50
Score3/3
Weight-26.49%
1M Return3.31%
Cash-MV
Value0.14
Score1/3
Weight28.47%
1M Return-5.64%
Value0.14
Score1/3
Weight28.47%
1M Return-5.64%
Net profit / Total profit (%)
Value90.66
Score1/3
Weight16.25%
1M Return-2.89%
Value90.66
Score1/3
Weight16.25%
1M Return-2.89%
Is IART undervalued or overvalued?
- IART scores 1.14/10 on fundamentals and holds a Premium valuation at present. Backed by its -39.86% ROE, -30.15% net margin, -1.77 P/E ratio, 0.85 P/B ratio, and -7987.50% earnings growth, these metrics solidify its Underperform investment rating.
